Zostavax® GP Decision Aid
Confidently identify patients who may be contra-indicated for shingles vaccine by using the Zostavax® GP Decision Aid.
Zostavax® contains live attenuated varicella-zoster virus, containing 14 times more virus than the childhood varicella vaccine. Inadvertent administration to immunocompromised people is associated with a risk of disseminated disease from the vaccine virus.
Remember to target the age eligible 70 to 79 year old age cohort for Zostavax®. Check vaccine records first to confirm that the patient has not already had a dose.
All vaccine doses should be reported to the Australian Immunisation Register.
The Zostavax® GP Decision Aid identifies patients who may be contra-indicated for shingles vaccine.
The Melbourne Vaccine Education Centre also provides a range of other resources about shingles.